Hermann Katinger and his team at Polymun Scientific are working on the corona vaccine made in Austria. The microbiologist is considered a biotech pioneer. He already focused on the future several years ago with the idea of influenza vaccination via spray instead of needle prick. In 1992, he founded Polymun, which develops bioprocesses and products for clinical testing, as well as vaccines against Alzheimer’s disease and special reagents for HIV research.
The development of the Institute of Applied Microbiology at the University of Natural Resources and Applied Life Sciences into a globally recognized center of excellence in modern biotechnology can be traced back to Katinger. The BOKU graduate pioneered the production of biopharmaceuticals with mammalian cells and their introduction into industrial mass production. Today, more than 80 percent of biopharmaceuticals are produced on this basis. His awards include the ESACT Medal of the European Society for Animal Cell Technology.